8MV0 (8MV0) News
Follow 8MV0 (8MV0) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BioHarvest Sciences Inc. (8MV0) Authorizes Buyback Up To 5% Of Shares
BioHarvest Sciences authorized a normal course issuer bid to repurchase up to 5% of outstanding common shares (max 1,133,392), to be executed on Nasdaq under Rule 10b-18. Repurchased shares will be retired.Material Detai
EQUITY | Sep 29, 2026, 11:01 AM UTC
H
BioHarvest Sciences Announces Share Repurchase Program
Vancouver, British Columbia and Rehovot, Israel--(. - September 29, 2026) - BioHarvest Sciences Inc. NASDAQ:BHST TASE:BHST (FSE: 8MV0) ("BioHarvest" or the "Company"), a Botanical Synthesis company developing and manufac
GEOPOLITICS | Sep 29, 2026, 11:01 AM UTC
L
BioHarvest Sciences announces intention to dual list on TASE
BioHarvest Sciences Inc. said it intends to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE). The company listed its existing NASDAQ and FSE share tickers in the announcement.
GEOPOLITICS | Sep 03, 2026, 11:06 AM UTC
L
Q3 Virtual Investor Summit Presentations Now Available On Demand
Q3 Virtual Investor Summit Presentations Now Available On Demand
EQUITY | Aug 31, 2026, 10:15 PM UTC
L
BioHarvest Sciences: Patented plant cell culture platform drives scalable growth and strong revenue outlook
BioHarvest Sciences: Patented plant cell culture platform drives scalable growth and strong revenue outlook
EARNINGS | Aug 26, 2026, 01:58 PM UTC
L
BioHarvest Sciences: Scalable plant cell technology, validated by VINIA, underpins strong growth and major partnerships
BioHarvest Sciences: Scalable plant cell technology, validated by VINIA, underpins strong growth and major partnerships
EQUITY | Aug 26, 2026, 01:35 PM UTC